BTX - Blood Product Transfusion/Disposition Segment

HL7 Attribute Table - BTX - Blood Product Transfusion/Disposition Segment

Seq#	Data Element Name	DataType	Usage	Vocabulary	Cardinality	Item #	Length	C.LEN	Flags
BTX
1	Set ID – BTX	SI	R		[1..1]	01735	[1..4]
2	BC Donation ID	EI	C		[0..1]	01736
3	BC Component	CNE	C	0582	[0..1]	01737
4	BC Blood Group	CNE	C	0583	[0..1]	01738
5	CP Commercial Product	CWE	C	0512 Commercial Product	[0..1]	01739
6	CP Manufacturer	XON	C		[0..1]	01740
7	CP Lot Number	EI	C		[0..1]	01741
8	BP Quantity	NM	R		[1..1]	01742		5	#
9	BP Amount	NM	O		[0..1]	01743		5	#
10	BP Units	CWE	O	0584	[0..1]	01744
11	BP Transfusion/Disposition Status	CWE	R	0513(R) Blood Product Transfusion/Disposition Status(Required)	[1..1]	01745
12	BP Message Status	ID	R	0511(R) BP Observation Status Codes Interpretation(Required)	[1..1]	01746	[1..1]
13	BP Date/Time of Status	DTM	R		[1..1]	01747
14	BP Transfusion Administrator	XCN	O		[0..1]	01748
15	BP Transfusion Verifier	XCN	O		[0..1]	01749
16	BP Transfusion Start Date/Time of Status	DTM	O		[0..1]	01750
17	BP Transfusion End Date/Time of Status	DTM	O		[0..1]	01751
18	BP Adverse Reaction Type	CWE	O	0514 Transfusion Adverse Reaction	[0..*]	01752
19	BP Transfusion Interrupted Reason	CWE	O	0515 Transfusion Interrupted Reason	[0..1]	01753
20	BP Unique ID	EI	O		[0..1]	03391
21	Action Code	ID	O	0206(R) Segment Action Code(Required)	[0..1]	00816	[2..2]

BTX-1: Set ID – BTX (SI) 01735

Definition: This field contains the sequence number for the BTX segment under the related BPO segment. For the first product transfusion/disposition transmitted, the sequence number shall be 1; for the second product transfusion/disposition, it shall be 2; and so on.

BTX-2: BC Donation ID (EI) 01736

Definition: The donation ID is the unique identification number assigned to a blood donation. The Donation ID depends upon the bar code labeling system used for the component. There are currently two blood component labeling standards: ABC CODABAR and ISBT 128. The preferred labeling system is ISBT 128. If using ISBT 128, the Donation ID is an internationally unique identifier consisting of the following 13 characters:

    Country Code & Collection Facility - 5 characters

    Donation Year - 2 characters

    Serial Number - 6 characters

This is required for blood components and is not applicable for commercial product messages.

BTX-3: BC Component (CNE) 01737

Definition: The Blood Component field includes an identifier and description of the specific blood component. Refer to Table 0582 - BC Component in Chapter 2C for valid values.

The identifier consists of a numeric or alphanumeric product code that represents the type of blood component. The coding system will be determined by the bar code labeling system on the particular component of blood. The preferred coding system is ISBT 128.

If using ISBT 128 labeling standard, the product code will consist of an 8-character alphanumeric code, starting with an alpha character and including the component class, donation type/intended use and division indicator.

If using CODABAR product labeling standard, the product code is a 5-digit number.

This field is required for blood components and is not applicable for commercial product messages.

BTX-4: BC Blood Group (CNE) 01738

Definition: This field indicates the ABO/Rh blood group of the blood component. The preferred values for the blood group are the specified values in Table 3A - Encodation of ABO/Rh Blood Group in the ISBT 128 Application Specification. Refer to Table 0583 - BC Blood Group in Chapter 2C for valid values.

This field is required for blood components and certain commercial products (such as solvent detergent plasma).

BTX-5: CP Commercial Product (CWE) 01739

Definition: This field contains the code and/or text to identify a commercial product. Examples of commercial products are blood derivatives such as Rh Immune Globulin and Factor VIII concentrate, Leukoreduction filters, and blood administration sets.

Either code and/or text may be absent. However, the code is always placed in the first component position and any free text in the second component. Thus, free text without a code must be preceded by a component delimiter. Free text can be utilized if no update is to occur. Refer to User-Defined Table 0512 - Commercial Product in Chapter 2C, Code Tables, for suggested values.

This field is required for commercial blood products and is not applicable to blood component messages.

BTX-6: CP Manufacturer (XON) 01740

Definition: This field identifies the manufacturer of the commercial product. The manufacturer may not be the same as the supplier of the commercial product.

This field is required for commercial blood products and is not applicable for blood component messages.

BTX-7: CP Lot Number (EI) 01741

Definition: This field identifies the lot number for blood derivatives or commercially supplied items used as accessories to transfusion.

This field is required for commercial blood products and is not applicable for blood component messages.

BTX-8: BP Quantity (NM) 01742

Definition: This field indicates the number of blood components or commercial products to which the message refers.

BTX-9: BP Amount (NM) 01743

Definition: This field contains the amount (volume) associated with each blood component or commercial product. When included in this segment, it may be used to indicate the volume of the blood component or product that was actually transfused.

BTX-10: BP Units (CWE) 01744

Definition: This field contains the units of measure for the blood component or commercial product amount. (See Chapter 7 for more details about reporting units.) This specifies the units of measure for volume of a blood component (i.e., 50 ml) or the units of measure or dosage of a commercial product (i.e., 910 I.U. - International Units - of Factor VIII Concentrate). Refer to Table 0584 - BP Units in Chapter 2C for valid values.

BTX-11: BP Transfusion/Disposition Status (CWE) 01745

Definition: This field indicates the current status of the specified blood product as indicated by the placer. For example, the placer may return the blood product to the transfusion service unused because an IV could not be started. The blood component may have been entered, but the line was clogged and could not be used, in which case the component must be wasted. A final status would indicate that the product has actually been "transfused." Refer to HL7 Table 0513 - Blood Product Transfusion/Disposition Status in Chapter 2C, Code Tables, for suggested values.

BTX-12: BP Message Status (ID) 01746

Definition: The most commonly used message status values in a BTX will be preliminary and final. A status is considered preliminary until a blood product has reached a final disposition for the patient. For example, when the product is first cross-matched and a status message is sent, it would be considered preliminary. When the product is dispensed to the patient, that status would also be considered preliminary. However, once the product is transfused, the status would be considered final. The status of a blood product (BTX-11) can continue to change and the previous result should be overwritten until it reaches a final status (BTX-12). Refer to HL7 Table 0511 – BP Observation Status Codes Interpretation in Chapter 2C, Code Tables, for valid entries.

BTX-13: BP Date/Time of Status (DTM) 01747

Definition: This field indicates the date and time that the status of the blood component was changed. For example, if the blood component had a status of "TX" (Transfused), the date and time in this field would indicate the date and time the component was transfused by the placer system.

BTX-14: BP Transfusion Administrator (XCN) 01748

Definition: This field contains the identity of the individual who administers the transfusion of the blood product. If the code is sent as a local code, it should be unique and unambiguous. This field can be free text to permit capture without table update. In this case, the administrator's name must be recorded as the second through fourth components of the field.

BTX-15: BP Transfusion Verifier (XCN) 01749

Definition: This field contains the identity of the individual who assists in the identification of the patient and verification of the product information prior to transfusion of the blood product. If the ID Number is sent as a local code, it should be unique and unambiguous. This field can be free text to permit capture without table update. In this case, the verifier's name must be recorded as the second through fourth components of the field.

BTX-16: BP Transfusion Start Date/Time of Status (DTM) 01750

Definition: This field indicates the date and time that the administrator started the transfusion of the blood component or commercial product.

BTX-17: BP Transfusion End Date/Time of Status (DTM) 01751

Definition: This field indicates the date and time that the transfusion of the blood component or commercial product was completed or stopped.

BTX-18: BP Adverse Reaction Type (CWE) 01752

Definition: This field contains the type of adverse reaction that the recipient of the blood product experienced. Refer to User-Defined Table 0514 - Transfusion Adverse Reaction in Chapter 2C, Code Tables, for suggested values.

BTX-19: BP Transfusion Interrupted Reason (CWE) 01753

Definition: This field contains the reason that the transfusion of the blood product was interrupted. Refer to User-Defined Table 0515 - Transfusion Interrupted Reason in Chapter 2C, Code Tables, for suggested values.

BTX-20: BP Unique ID (EI) 03391

Definition: This field is a unique system-generated number assigned to the blood product to which the message is referring. Each time the status is updated, the new message should replace the previous message if the Blood Product Unique ID is the same. If the Blood Product Unique ID is different, it indicates that the status applies to a different blood product.

BTX-21: Action Code (ID) 00816

Definition: This field reveals the intent of the message. Refer to HL7 Table 0206 - Segment Action Code for valid values.

The action code can only be used when an BTX is uniquely identified sufficiently within the specific implementation using BTX-20 or BTX-3 as agreed to by the trading partners in accordance with Chapter 2, Section 2.10.4.2.